Guest: Bob Roda

This is a quarterly recap of our top episodes. You'll hear some of the highlights from several guests. From Bob Rhoda, CEO of Hemisonics, a medical device technology company, to Colleen Vassalette, CEO of landscape design firm Intrigue Design, Ryan P. Clark, co-founder and CEO of staffing and recruitment firm PeopleShare, and Will Bowie, founder and CEO of Empower Construction, a utility construction firm in greater Philadelphia, just to name a few.
Will's mother summed up what made every episode this quarter a compounding message of the power of being intentional. She inspired Will and his brother to be intentional about being the best at whatever they did, whomever they became. And Will showed up just like all the other guests this quarter with capability, confidence, and purpose. Take a listen to some of the highlights.
 
The full list is here.
 

CEOs are often laser-focused on destinations—quarterly targets, market share goals, and exit strategies. But what if the true measure of leadership lies in valuing the journey as much as the endpoint? This insight comes from a recent conversation with Bob Rhoda, CEO of Hemasonics, who emphasizes the fulfillment of embracing daily experiences. As someone who regularly engages with CEOs, I've observed a common fixation on end results. However, reflecting on my own career and those of successful leaders, it's clear that real value often emerges from the collective moments of triumph, failure, and growth along the way. This commentary explores the power of balancing destination-driven goals with an appreciation for the journey, offering a fresh perspective on leadership and organizational success that resonates in today's dynamic business landscape.
About our guest:
Robert A. Roda (Bob) joined HemoSonics in February 2020 as the company’s President and CEO, bringing more than 25 years of global experience developing and commercializing innovative diagnostic and medical device products and services.Most recently, Bob Roda served as President and CEO of Menarini Silicon Biosystems, Inc., a diagnostic and biotech company focused on the use of liquid biopsy and predictive diagnostic tests for the treatment of cancer patients. Prior to that position, he was Vice President and General Manager at Becton Dickinson, where he led the medical and procedural solutions business in the US. From 1998-2012, Bob held positions of increasing responsibility at Johnson & Johnson in both the medical device and diagnostic sectors, with his last role being worldwide VP Marketing in Immunohematology, Donor Screening, and Clinical Laboratories at Ortho Clinical Diagnostics, a J&J company. Bob earned a Bachelor of Arts in Economics from the University of Rhode Island and completed postgraduate coursework at Kellogg Graduate School of Management.
Links from this episode:
HemoSonics website 
HemoSonics YouTube channel:  
X @HemoSonics
HemoSonics on LinkedIn 
Deborah Fell on LinkedIn
Chief Outsiders

In this episode, Deborah welcomes Bob Roda, President and CEO of HemoSonics, about purpose-driven leadership in healthcare. Bob shares his journey from an economics major to a passionate advocate for improving patient care. He offers candid insights from his career at Johnson & Johnson to his current role in medical technology innovation.
Bob's story emphasizes continuous learning and embracing both successes and failures. He provides a fresh take on leadership, stressing the importance of the journey as much as the destination. Bob's commitment to making a meaningful impact in healthcare is evident throughout the conversation.
Join us for this engaging discussion on mentorship, the value of experience, and the challenges of driving change in clinical practice. Bob's insights offer valuable perspective for those at any stage of their career in, “Balancing the Blood Ledger: HemoSonics CEO on Innovation and Patient Care.”
About our guest:
Robert A. Roda (Bob) joined HemoSonics in February 2020 as the company’s President and CEO, bringing more than 25 years of global experience developing and commercializing innovative diagnostic and medical device products and services.Most recently, Bob Roda served as President and CEO of Menarini Silicon Biosystems, Inc., a diagnostic and biotech company focused on the use of liquid biopsy and predictive diagnostic tests for the treatment of cancer patients. Prior to that position, he was Vice President and General Manager at Becton Dickinson, where he led the medical and procedural solutions business in the US. From 1998-2012, Bob held positions of increasing responsibility at Johnson & Johnson in both the medical device and diagnostic sectors, with his last role being worldwide VP Marketing in Immunohematology, Donor Screening, and Clinical Laboratories at Ortho Clinical Diagnostics, a J&J company. Bob earned a Bachelor of Arts in Economics from the University of Rhode Island and completed postgraduate coursework at Kellogg Graduate School of Management.
Links from this episode:
HemoSonics website 
HemoSonics YouTube channel:  
X @HemoSonics
HemoSonics on LinkedIn 
Deborah Fell on LinkedIn
Chief Outsiders